Does CEFPODOXIME Cause Bladder transitional cell carcinoma? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Bladder transitional cell carcinoma have been filed in association with CEFPODOXIME. This represents 3.8% of all adverse event reports for CEFPODOXIME.
15
Reports of Bladder transitional cell carcinoma with CEFPODOXIME
3.8%
of all CEFPODOXIME reports
0
Deaths
15
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From CEFPODOXIME?
Of the 15 reports, 15 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEFPODOXIME. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does CEFPODOXIME Cause?
Pruritus (22)
Pyrexia (22)
Drug ineffective (21)
Vomiting (20)
Toxicity to various agents (18)
Acute generalised exanthematous pustulosis (17)
Condition aggravated (17)
Nausea (17)
Agranulocytosis (16)
Clostridium difficile colitis (15)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which CEFPODOXIME Alternatives Have Lower Bladder transitional cell carcinoma Risk?
CEFPODOXIME vs CEFPODOXIME PROXETIL
CEFPODOXIME vs CEFPROZIL
CEFPODOXIME vs CEFTAROLINE
CEFPODOXIME vs CEFTAROLINE FOSAMIL
CEFPODOXIME vs CEFTAZIDIME